Funding for this research was provided by:
Pfizer (Investigator-initiated grant)
Heart Foundation / New South Wales Health Cardiovascular Research Network Research Development Project Grant (101133)
AliveCor (Provided free smartphone ECG covers for the studies)
Text and Data Mining valid from 2019-12-01
Received: 11 July 2019
Accepted: 22 November 2019
First Online: 6 December 2019
Ethics approval and consent to participate
: The AF-SMART studies had approval from the University of Sydney Human Research Ethics Committee (Protocol No. 2017/1017 and Protocol No. 2014/962). All practices and interviewees provided written informed consent.
: Not applicable.
: JL, RG: none. JO and NL: investigator-initiated grants from Pfizer/ Bristol-Myers Squibb (BMS). LN grants from Pfizer/BMS and Bayer and honoraria from Pfizer/BMS, Bayer and Boehringer Ingelheim. BF reports prior fees and advisory board honoraria from Bayer Pharma AG, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer/BMS.